Logo-apb
Adv Pharm Bull. 2020;10(3): 334-337.
doi: 10.34172/apb.2020.041
  Abstract View: 88
  PDF Download: 98

Editorial

Safe ِِِDrugs Versus Innovative Drugs (Can We Have Both?)

Vera Lúcia Raposo * ORCID logo

Abstract

Drugs are especially dangerous products, and because of this they need to undergo a very demanding evaluation process before they reach the market. Drugs are also essential for promoting and maintaining health, improving quality of life and even avoiding death. Too many restrictions on them may cause a shortage in the availability of new drugs. The process of drug approval must therefore be demanding enough to select only the safest drugs, but not so demanding that patients are deprived of essential new therapeutic alternatives. The solution rests in investing more in pharmacovigilance to promote patient safety without limiting innovation.
Keywords: drug approval, adverse drug reaction, pharmacovigilance, patient safety
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 88

Your browser does not support the canvas element.


PDF Download: 98

Your browser does not support the canvas element.

Submitted: 23 May 2019
Revision: 11 Dec 2019
Accepted: 12 Dec 2019
ePublished: 14 Dec 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)